Immunization, HepB3 in East Asia & Pacific (excluding high income)
East Asia & Pacific (excluding high income): Immunization, HepB3 was 87.4% in 2024. ◆ Volatile
Immunization, HepB3 in East Asia & Pacific (excluding high income), 1985–2024
Source: World Health Organization (WHO). Measured in % of one-year-old children.
Analysis
East Asia & Pacific (excluding high income) recorded 87.4% for immunization, hepb3 in 2024.
That represents a change of down 0.7% on the previous year and down 7.5% over ten years.
Over the whole period, immunization, hepb3 in East Asia & Pacific (excluding high income) peaked at 94.4% in 2014 and was at its lowest, 0.0%, in 1985.
East Asia & Pacific (excluding high income) ranks 16th of 47 groups on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Immunization, HepB3 in East Asia & Pacific (excluding high income), year by year
| Year | % of one-year-old children | Change |
|---|---|---|
| 1985 | 0.0% | — |
| 1986 | 0.0% | — |
| 1987 | 0.0% | — |
| 1988 | 0.0% | — |
| 1989 | 0.9% | — |
| 1990 | 1.2% | +33.3% |
| 1991 | 1.2% | +3.6% |
| 1992 | 5.1% | +326.6% |
| 1993 | 9.2% | +77.9% |
| 1994 | 9.8% | +7.1% |
| 1995 | 14.8% | +51.1% |
| 1996 | 16.9% | +14.0% |
| 1997 | 17.6% | +4.0% |
| 1998 | 19.7% | +12.4% |
| 1999 | 20.5% | +3.7% |
| 2000 | 51.8% | +152.9% |
| 2001 | 57.2% | +10.6% |
| 2002 | 59.9% | +4.7% |
| 2003 | 68.4% | +14.2% |
| 2004 | 73.1% | +6.8% |
| 2005 | 77.0% | +5.4% |
| 2006 | 85.0% | +10.3% |
| 2007 | 87.0% | +2.3% |
| 2008 | 91.0% | +4.6% |
| 2009 | 94.1% | +3.4% |
| 2010 | 94.0% | -0.1% |
| 2011 | 92.6% | -1.5% |
| 2012 | 93.9% | +1.4% |
| 2013 | 92.9% | -1.0% |
| 2014 | 94.4% | +1.6% |
| 2015 | 93.6% | -0.9% |
| 2016 | 94.3% | +0.7% |
| 2017 | 94.2% | -0.2% |
| 2018 | 93.2% | -1.0% |
| 2019 | 93.6% | +0.3% |
| 2020 | 91.9% | -1.8% |
| 2021 | 85.8% | -6.6% |
| 2022 | 92.8% | +8.2% |
| 2023 | 88.0% | -5.2% |
| 2024 | 87.4% | -0.7% |
Biggest year-on-year movements
Years where Immunization, HepB3 in East Asia & Pacific (excluding high income) changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 1992 | +326.6% | 1.2% | 5.1% |
| 2000 | +152.9% | 20.5% | 51.8% |
| 1993 | +77.9% | 5.1% | 9.2% |
| 1995 | +51.1% | 9.8% | 14.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 0.2% | 0.0% | 0.9% | 5 |
| 1990s | 11.6% | 1.2% | 20.5% | 10 |
| 2000s | 74.5% | 51.8% | 94.1% | 10 |
| 2010s | 93.7% | 92.6% | 94.4% | 10 |
| 2020s | 89.2% | 85.8% | 92.8% | 5 |
Countries ranked near East Asia & Pacific (excluding high income)
- 19 Belarus 98.0% compare
- 19 Bhutan 98.0% compare
- 19 Guyana 98.0% compare
- 19 Iran, Islamic Republic of 98.0% compare
- 19 Kazakhstan 98.0% compare
- 19 Luxembourg 98.0% compare
- 19 Rwanda 98.0% compare
More health data for East Asia & Pacific (excluding high income)
- Population ages 35-39, female, annual growth rate 2.31 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0353 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 1.78 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0424 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 2.76 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0396 units per person (2025)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 25-29, male, per capita 0.0341 units per person (2025)
Frequently asked questions
- What is immunization, hepb3 in East Asia & Pacific (excluding high income)?
- Immunization, hepb3 in East Asia & Pacific (excluding high income) was 87.4% in 2024, according to World Health Organization (WHO).
- What is the highest immunization, hepb3 recorded in East Asia & Pacific (excluding high income)?
- The highest recorded value was 94.4% in 2014.
- What is the lowest immunization, hepb3 recorded in East Asia & Pacific (excluding high income)?
- The lowest recorded value was 0.0% in 1985.
- How does East Asia & Pacific (excluding high income) rank for immunization, hepb3?
- East Asia & Pacific (excluding high income) ranks 16th out of 47 groups with data for 2024.
- Is immunization, hepb3 rising or falling in East Asia & Pacific (excluding high income)?
- Over the last ten years it is down 7.5%. The long-run trend across the full record is volatile.
- Where does this East Asia & Pacific (excluding high income) data come from?
- The figures come from World Health Organization (WHO), published as part of Immunization, HepB3 (% of one-year-old children). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 40 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.